Shanghai Zhimeng Pharmaceutical Technology Co., Ltd.
挚盟医药
Shanghai Zhimeng Pharmaceutical Technology Co., Ltd.
Biotech/Healthcare
Zhimeng Pharmaceuticals is a biopharmaceutical R&D company focused on developing innovative drugs for chronic hepatitis B and central nervous system diseases. Its product pipeline covers multiple mechanisms of the hepatitis B virus lifecycle, including nucleocapsid inhibitors that block viral…
Latest round: Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.